Transcriptional profiling of γδ T cells identifies a role for vitamin D in the immunoregulation of the Vγ9Vδ2 response to phosphate-containing ligands

被引:56
作者
Chen, LF
Cencioni, MT
Angelini, DF
Borsellino, G
Battistini, L
Brosnan, CF
机构
[1] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA
[2] Inst Sci, Santa Lucia Fdn, Neuroimmunol Unit, Rome, Italy
关键词
D O I
10.4049/jimmunol.174.10.6144
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vitamin D is a steroid hormone that, in addition to its well-characterized role in calcium/phosphate metabolism, has been found to have regulatory properties for immune system function. The nuclear vitamin D receptor is widely expressed in tissues, but has also been shown to be regulated by hormones, growth factors, and cytokines. In this study we show that activation of human V delta 2V gamma 9 T cells by nonpeptidic monoalkyl phosphates such as isopentenyl pyrophosphate leads to the up-regulation of the vitamin D receptor via a pathway that involves the classical isoforms of protein kinase C. We further show that this receptor is active by demonstrating that the ligand 1 alpha,25-dihydroxyvitamin D3 (vitD3) significantly inhibits in a dose-dependent fashion phospholigand-induced gamma delta T cell expansion, IFN-gamma production, and CD25 expression. We also show that vitD3 negatively regulates signaling via Akt and ERK and, at high concentrations, potentiates Ag-induced cell death. As such, these data provide further support for the immunoregulatory properties of vitamin D, and suggest that the ability of vitD3 to negatively regulate the proinflammatory activity of gamma delta T cells may contribute to the protection this vitamin affords against inflammatory and autoimmune disorders dependent upon Th1-type responses.
引用
收藏
页码:6144 / 6152
页数:9
相关论文
共 63 条
[1]   FcγRIII discriminates between 2 subsets of Vγ9Vδ2 effector cells with different responses and activation pathways [J].
Angelini, DF ;
Borsellino, G ;
Poupot, M ;
Diamantini, A ;
Poupot, R ;
Bernardi, G ;
Poccia, F ;
Fournié, JJ ;
Battistini, L .
BLOOD, 2004, 104 (06) :1801-1807
[2]   Integration of hormone signaling in the regulation of human 25(OH) D3 24-hydroxylase transcription [J].
Barletta, F ;
Dhawan, P ;
Christakos, S .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2004, 286 (04) :E598-E608
[3]   In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines [J].
Barrat, FJ ;
Cua, DJ ;
Boonstra, A ;
Richards, DF ;
Crain, C ;
Savelkoul, HF ;
de Waal-Malefyt, R ;
Coffman, RL ;
Hawrylowicz, CM ;
O'Garra, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) :603-616
[4]   MULTIPLE-SCLEROSIS - LIMITED DIVERSITY OF THE V-DELTA-2-J-DELTA-3 T-CELL RECEPTOR IN CHRONIC ACTIVE LESIONS [J].
BATTISTINI, L ;
SELMAJ, K ;
KOWAL, C ;
OHMEN, J ;
MODLIN, RL ;
RAINE, CS ;
BROSNAN, CF .
ANNALS OF NEUROLOGY, 1995, 37 (02) :198-203
[5]   SPECIFIC HIGH-AFFINITY RECEPTORS FOR 1,25-DIHYDROXYVITAMIN-D3 IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS - PRESENCE IN MONOCYTES AND INDUCTION IN LYMPHOCYTES-T FOLLOWING ACTIVATION [J].
BHALLA, AK ;
AMENTO, EP ;
CLEMENS, TL ;
HOLICK, MF ;
KRANE, SM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (06) :1308-1310
[6]  
BOON PI, 2000, BIODIVERSITY WETLAND, V1, P1
[7]   NON-HYPERCALCEMIC PHARMACOLOGICAL ASPECTS OF VITAMIN-D ANALOGS [J].
BOUILLON, R ;
VERSTUYF, A ;
VERLINDEN, L ;
ALLEWAERT, K ;
BRANISTEANU, D ;
MATHIEU, C ;
VANBAELEN, H .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (05) :577-583
[8]   Vitamin D [J].
Brown, AJ ;
Dusso, A ;
Slatopolsky, E .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1999, 277 (02) :F157-F175
[9]  
BUKOWSKI JF, 1995, J IMMUNOL, V154, P998
[10]   1,25-dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease [J].
Cantorna, MT ;
Munsick, C ;
Bemiss, C ;
Mahon, BD .
JOURNAL OF NUTRITION, 2000, 130 (11) :2648-2652